Literature DB >> 29511442

SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.

Jian Zhao1, Jian Xu1, Rui Zhang1.   

Abstract

Colon cancer is one of common cancer in the world and glycolysis is one of the major problems in colon cancer therapy. MicroRNAs (miRNAs) involve in colon cancer progression. Sushi repeat-containing protein X-linked 2 (SRPX2) is associated with poor prognosis in some cancer patients, however, the role of SRPX2 including glycolytic metabolism regulated by miRNAs is unclear in colon cancer. So, the purpose of the present study is to elucidate the underlying mechanism in colon cancer metabolism mediated by SRPX2. Our results revealed that miR-192-5p (miR-192) and miR-215-5p (miR-215) inhibited glycolysis by regulating SRPX2 expression in colon cancer cells. We also found that miR-192 and miR-215 were both regulated by PI3K-Akt. Our results indicate that SRPX2 facilitates colon cancer cell glycolysis by miR-192 and miR-215, which are down-regulated by PI3K-Akt.

Entities:  

Keywords:  PI3K-Akt; SRPX2; colon cancer; miR-192; miR-215

Year:  2018        PMID: 29511442      PMCID: PMC5835813     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  21 in total

1.  SRPX2 mutations in disorders of language cortex and cognition.

Authors:  Patrice Roll; Gabrielle Rudolf; Sandrine Pereira; Barbara Royer; Ingrid E Scheffer; Annick Massacrier; Maria-Paola Valenti; Nathalie Roeckel-Trevisiol; Sarah Jamali; Christophe Beclin; Caroline Seegmuller; Marie-Noëlle Metz-Lutz; Arnaud Lemainque; Marc Delepine; Christophe Caloustian; Anne de Saint Martin; Nadine Bruneau; Danièle Depétris; Marie-Geneviève Mattéi; Elisabeth Flori; Andrée Robaglia-Schlupp; Nicolas Lévy; Bernd A Neubauer; Rivka Ravid; Christian Marescaux; Samuel F Berkovic; Edouard Hirsch; Mark Lathrop; Pierre Cau; Pierre Szepetowski
Journal:  Hum Mol Genet       Date:  2006-02-23       Impact factor: 6.150

Review 2.  An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.

Authors:  Wenhao Weng; Junlan Feng; Huanlong Qin; Yanlei Ma; Ajay Goel
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

3.  Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.

Authors:  Bo Song; Yuan Wang; Matthew A Titmus; Galina Botchkina; Andrea Formentini; Marko Kornmann; Jingfang Ju
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

4.  MiR-215 modulates gastric cancer cell proliferation by targeting RB1.

Authors:  Yujie Deng; Zhenxia Huang; Yanjun Xu; Juan Jin; Wei Zhuo; Cheng Zhang; Xuting Zhang; Minhong Shen; Xiaoyi Yan; Liangjing Wang; Xiaojia Wang; Yibin Kang; Jianmin Si; Tianhua Zhou
Journal:  Cancer Lett       Date:  2013-08-24       Impact factor: 8.679

Review 5.  MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity.

Authors:  Michael Hollis; Kavitha Nair; Arpita Vyas; Lakshmi Shankar Chaturvedi; Sahil Gambhir; Dinesh Vyas
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

6.  SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells.

Authors:  Haitao Tang; Jiaxin Zhao; Liangyu Zhang; Jiang Zhao; Yongzhi Zhuang; Peng Liang
Journal:  Cell Mol Neurobiol       Date:  2015-12-07       Impact factor: 5.046

7.  Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR.

Authors:  Barbara Royer-Zemmour; Magali Ponsole-Lenfant; Hyam Gara; Patrice Roll; Christian Lévêque; Annick Massacrier; Géraldine Ferracci; Jennifer Cillario; Andrée Robaglia-Schlupp; Renaud Vincentelli; Pierre Cau; Pierre Szepetowski
Journal:  Hum Mol Genet       Date:  2008-08-21       Impact factor: 6.150

8.  Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer.

Authors:  Bodil Øster; Lene Linnet; Lise Lotte Christensen; Kasper Thorsen; Halit Ongen; Emmanouil T Dermitzakis; Juan Sandoval; Sebastian Moran; Manel Esteller; Torben F Hansen; Philippe Lamy; Søren Laurberg; Torben F Ørntoft; Claus L Andersen
Journal:  Int J Cancer       Date:  2012-11-21       Impact factor: 7.396

9.  Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.

Authors:  Noelyn A Hung; Ramona A Eiholzer; Stenar Kirs; Jean Zhou; Kirsten Ward-Hartstonge; Anna K Wiles; Chris M Frampton; Ahmad Taha; Janice A Royds; Tania L Slatter
Journal:  Mod Pathol       Date:  2016-01-15       Impact factor: 7.842

10.  microRNA-192 suppresses the expression of the farnesoid X receptor.

Authors:  Regina Krattinger; Adrian Boström; Helgi B Schiöth; Wolfgang E Thasler; Jessica Mwinyi; Gerd A Kullak-Ublick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-14       Impact factor: 4.052

View more
  11 in total

Review 1.  miRNA Clusters with Down-Regulated Expression in Human Colorectal Cancer and Their Regulation.

Authors:  Paulína Pidíkova; Richard Reis; Iveta Herichova
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

2.  Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.

Authors:  Bing Chen; Zijing Xia; Ya-Nan Deng; Yanfang Yang; Peng Zhang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  Open Biol       Date:  2019-01-31       Impact factor: 6.411

3.  Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Yukiko Nishiguchi; Hiroyuki Shimomura; Tadaaki Kirita
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

4.  Influence of high glucose in the expression of miRNAs and IGF1R signaling pathway in human myometrial explants.

Authors:  Udo R Markert; Telma M T Zorn; Rodolfo R Favaro; Diana M Morales-Prieto; Jörg Herrmann; Jürgen Sonnemann; Ekkehard Schleussner
Journal:  Arch Gynecol Obstet       Date:  2021-02-11       Impact factor: 2.344

Review 5.  Sushi-Repeat-Containing Protein X-Linked 2: A Potential Therapeutic Target for Inflammation and Cancer Therapy.

Authors:  Jinhua Chen; Zhenhua Yin; Wenping Song; Baoxia He; Wenzhou Zhang
Journal:  J Immunol Res       Date:  2022-07-28       Impact factor: 4.493

6.  Construction of a miRNA-mRNA Network Related to Exosomes in Colon Cancer.

Authors:  Wanhui Dong; Dezhen Wu; Sheng Xu; Qingming Sun; Xueping Ci
Journal:  Dis Markers       Date:  2022-07-05       Impact factor: 3.464

Review 7.  Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer.

Authors:  Pirouz Pourmohammad; Nazila Fathi Maroufi; Mohsen Rashidi; Vahid Vahedian; Farhad Pouremamali; Yousef Faridvand; Mahsa Ghaffari-Novin; Alireza Isazadeh; Saba Hajazimian; Hamid Reza Nejabati; Mohammad Nouri
Journal:  Biochem Genet       Date:  2021-06-28       Impact factor: 1.890

8.  Comparing of backfat microRNAomes of Landrace and Neijiang pig by high-throughput sequencing.

Authors:  Yanyue Li
Journal:  Genes Genomics       Date:  2021-03-16       Impact factor: 1.839

9.  A five-miRNA panel in plasma was identified for breast cancer diagnosis.

Authors:  Minghui Li; Xuan Zou; Tiansong Xia; Tongshan Wang; Ping Liu; Xin Zhou; Shui Wang; Wei Zhu
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

10.  Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis.

Authors:  Lili Wang; Yuhan Liu; Chen Lyu; Alexander Buchner; Heike Pohla
Journal:  Biomed Res Int       Date:  2021-02-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.